$16.52
0.030.18%
Últ. Act.: Nov 6, 12:41 PM
NeoGenomics (NEO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
NeoGenomics (NEO) publicó su última previsión de octubre 28, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $807M - $809M para el período.
En comparación con la previsión anterior, NeoGenomics mantenido redujo su previsión de ingresos desde un rango anterior de $802M - $806M.
NeoGenomics ha emitido 25 actualizaciones de orientación entre el febrero 23, 2023 y el octubre 28, 2026. During this period, the company raised its outlook 9 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.04 | $0.01 | $-0.02 | $0.01 |
| Actual | $0.07 | $0.05 | $0.01 | $0.06 |
| Surprise | +75.0% | +400.0% | +150.0% | +500.0% |
| Revenue | ||||
| Estimate | $207.4M | $197.0M | $184.5M | $188.4M |
| Actual | $209.3M | $202.0M | $186.7M | $190.2M |
| Surprise | +0.90% | +2.52% | +1.19% | +0.96% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.07 | $0.04 | $0.01 | $0.01 |
| Revenue | ||||
| Consensus | $210.5M | $206.2M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 28, 2026 | $0.07 | $0.04 | 75.0 % |
| Q2 | Jul 28, 2026 | $0.05 | $0.01 | 400.0 % |
| Q1 | Apr 28, 2026 | $0.01 | $-0.02 | 150.0 % |
| Q4 | Feb 17, 2026 | $0.06 | $0.01 | 500.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 28, 2026 | $209.25M | $207.38M | 0.90 % |
| Q2 | Jul 28, 2026 | $202.00M | $197.04M | 2.52 % |
| Q1 | Apr 28, 2026 | $186.67M | $184.47M | 1.19 % |
| Q4 | Feb 17, 2026 | $190.17M | $188.36M | 0.96 % |